Question 1

What are the most cited papers from Vasopharm (Germany)?

Accepted Answer

The most cited paper from Vasopharm (Germany) is "The NOX toolbox: validating the role of NADPH oxidases in physiology and disease" (Sebastian Altenhöfer, Pamela W. M. Kleikers, Kim A. Radermacher et al., 2012), with 386 citations. Next come "Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation☆" (255) and "Comparative pharmacology of chemically distinct NADPH oxidase inhibitors" (239).

Question 2

Which research topics does Vasopharm (Germany) publish most on?

Accepted Answer

By volume: Nitric Oxide and Endothelin Effects, Metabolism and Genetic Disorders, Phosphodiesterase function and regulation and Receptor Mechanisms and Signaling.

Question 3

Which fields of science does Vasopharm (Germany) work in?

Accepted Answer

In all years, 51% of research at Vasopharm (Germany) is in Health Sciences, 47% in Life Sciences. Its largest fields are Medicine (51%), Biochemistry, Genetics and Molecular Biology (38%), Immunology and Microbiology (6%). It does 1.7× the world's share of Life Sciences.

Question 4

Is Vasopharm (Germany)'s research output growing?

Accepted Answer

Output in 2022-2025 was 100% lower than in 2018-2021.